The Centers for Medicare & Medicaid Services (CMS) announced an 18% drop in Medicare Advantage contracts rated four stars or higher for 2027, due to changes in rating criteria including new medication-safety measures and increased weight on physical and mental health. Despite fewer contracts meeting the threshold, enrollment in these high-rated plans actually increased, indicating seniors still have access to quality options. This shift affects future quality-bonus payments and investor outlooks, with insurers like Humana benefiting from improved ratings and stock gains, while others face challenges. Investors should watch how insurers convert these rating changes into profitability amid rising healthcare costs.
Humana Inc shares rose 13.39% to USD 438.95 as of Oct 09, 2026 22:21 WIB on Pluang, reflecting strong investor interest possibly linked to its improved Medicare Advantage ratings. CVS Health Corp, another major insurer, traded down 1.16% at USD 86.78 during the same period. Humana's market cap stands at $46.49 billion, while CVS holds a larger market cap of $112.29 billion, showing differing investor valuations in the health sector.
Oppenheimer upgraded Humana's price target from $405 to $475, citing strong performance in Medicare Advantage plans where 95% of members are in four-star or higher rated plans. This upgrade implies a potential 22.7% upside from Humana's current stock...
Humana's shares rose nearly 15% after the company improved its Medicare Advantage quality ratings for 2027, with about 95% of members enrolled in plans rated at least four stars. The company now has 18 contracts rated four stars or higher, including ...
Humana's stock surged 16% after the company announced improved Medicare Advantage Star Ratings for 2027, with 95% of its members enrolled in plans rated four stars or higher. This improvement reflects better preventive care and earlier disease detect...
Nearly 1 million Medicare Advantage members face plan shutdowns from providers like UnitedHealth and Humana, risking loss of current coverage. While this reduces insurer costs and improves margins, affected members must act by December 7 to secure Me...
A court has allowed key claims in a securities fraud lawsuit against Humana and its former CEO and CFO to proceed. The lawsuit alleges Humana misled investors from July 2022 to October 2024 about rising costs as patients returned for care post-pandem...
